Prospera Financial Services’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.08M | Buy |
30,075
+1,112
| +4% | +$40K | 0.02% | 626 |
|
|
2025
Q1 | $1.14M | Sell |
28,963
-5,550
| -16% | -$219K | 0.03% | 528 |
|
|
2024
Q4 | $1.04M | Sell |
34,513
-1,200
| -3% | -$36.1K | 0.02% | 531 |
|
|
2024
Q3 | $835K | Sell |
35,713
-2,712
| -7% | -$63.4K | 0.02% | 551 |
|
|
2024
Q2 | $684K | Sell |
38,425
-665
| -2% | -$11.8K | 0.02% | 604 |
|
|
2024
Q1 | $595K | Buy |
39,090
+750
| +2% | +$11.4K | 0.02% | 649 |
|
|
2023
Q4 | $655K | Buy |
38,340
+6,865
| +22% | +$117K | 0.02% | 574 |
|
|
2023
Q3 | $263K | Buy |
31,475
+200
| +0.6% | +$1.67K | 0.01% | 852 |
|
|
2023
Q2 | $777K | Sell |
31,275
-6,000
| -16% | -$149K | 0.03% | 485 |
|
|
2023
Q1 | $561K | Buy |
37,275
+18,625
| +100% | +$280K | 0.02% | 577 |
|
|
2022
Q4 | $221K | Buy |
+18,650
| New | +$221K | 0.01% | 816 |
|
|
2022
Q3 | – | Sell |
-6,700
| Closed | -$28K | – | 1518 |
|
|
2022
Q2 | $28K | Sell |
6,700
-620
| -8% | -$2.59K | ﹤0.01% | 1142 |
|
|
2022
Q1 | $70K | Buy |
+7,320
| New | +$70K | ﹤0.01% | 1237 |
|